Please read the full Article with References
articles.mercola.com
There are several cell lines commonly used in vaccine development that originate from aborted fetuses, including:
- HEK293 — human embryonic cell line originally derived from kidney tissue obtained from a female fetus aborted in the Netherlands in 1972
- MRC5 — human embryonic cell line originally derived from the lung tissue of a 14-week-old male fetus aborted in 1966
- PER.C6 — human embryonic cell line originally derived from the retina of an 18-week-old male fetus aborted in the Netherlands in 1985
- WI38 — human embryonic cell line originally derived from the lung tissue of a 12-week-old female fetus aborted in 1961
Vaccine makers using at least one of these fetal cell lines in the development of their COVID-19 vaccines include:
|
AstraZeneca (HEK293) |
Jansen Research and Development (owned by Johnson & Johnson), (PER.C6) |
|
CanSino Biologics (HEK293) |
University of Pittsburgh (HEK293) |
|
ImmunityBio (HEK293) |
Altimmune (PER.C6) |
Residual DNA in Vaccines Linked to Autism?
Some may also object to vaccines manufactured through the use of fetal cell lines on the basis that there may be health risks involved, due to potential DNA contamination. In a 2011 scientific review, Helen Ratajczak, a former drug company scientist, linked the introduction of human fetal cell lines in vaccine production (among other things) to the rapid rise in autism. On page 70 of her paper, Ratajczak explains this particular connection….
Please read the full Article with References
articles.mercola.com
